The FDA's decision Aug. 11 could mark a major shift in PTSD treatment for veterans. MDMA-AT, more commonly known as ecstasy or molly, shows promising results in therapy.
In what could be a pivotal moment for the future of psychedelic medicine, the Food & Drug Administration is weighing a decision to approve MDMA-AT, also known as ecstasy or molly, to treat post-traumatic stress disorder. The FDA is expected to make a decision by Aug. 11. The decision will have a huge impact on military veterans who say the psychedelic drug has relieved their
, then everybody that goes to a rave wouldn't have trauma anymore,' Agrawal said. 'It's not a magic bullet. It does not work for everyone. But I have seen people really change.' Jonathan Lubecky is a retired Army sergeant who has been treated with MDMA. Lubecky has had a long battle with Now, Lubecky hopes the FDA will approve the use of MDMA so other veterans like him can get the treatment they need. 'I keep hope because the FDA will approve this, if not on Aug. 11, one day they will. The only question for the FDA is how many veterans, how many Americans' lives, between now and then?' Lubecky said. Last month, Lubecky joined a chorus of veterans on Capitol Hill to raise awareness about MDMA treatment.
The term psychedelics scares people. It scared me too,' Luttrell told Fox News. He described his personal journey on psychedelics as 'nothing short of an exorcism.' 'It allows you to address things that, you know, live and breathe and repress back in a deep cognitive spaces of your brain. And that's usually what people need,' Luttrell said, describing the treatment as 20 years of therapy in three days.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Can a lobbying push led by veterans help MDMA get approved for PTSD treatment?Advocates are still fighting to get the psychedelic drug approved as a mental health treatment, despite its rejection by the FDA's advisory committee in June. They face an uphill battle.
Read more »
Can a lobbying push led by veterans help MDMA get approved for PTSD treatment?Advocates are still fighting to get the psychedelic drug approved as a mental health treatment, despite its rejection by the FDA's advisory committee in June. They face an uphill battle.
Read more »
Bipartisan House and Senate group pushes Biden administration for MDMA treatment of PTSDPolitical News and Conservative Analysis About Congress, the President, and the Federal Government
Read more »
Veterans lobbied for psychedelic therapy, but it may not be enough to save MDMA drug applicationMilitary veterans have spent years lobbying for the use of psychedelic drugs to treat PTSD, but a sharply critical review of the club drug MDMA has put the therapy's approval in doubt.
Read more »
Veterans lobbied for psychedelic therapy, but it may not be enough to save MDMA drug applicationMilitary veterans have spent years lobbying for the use of psychedelic drugs to treat PTSD, but a sharply critical review of the club drug MDMA has put the therapy's approval in doubt.
Read more »
Veterans lobbied for psychedelic therapy, but it may not be enough to save MDMA drug applicationMilitary veterans have spent years lobbying for the use of psychedelic drugs to treat PTSD, but a sharply critical review of the club drug MDMA has put the therapy's approval in doubt.
Read more »